Cornell Pochily Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Cornell Pochily Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+1,140	New	+$196K	0.06%	186
2022 Q1	–	Sell	-1,409	Closed	-$215K	–	172
2021 Q4	$215K	Buy	1,409 +1	+0.1%	+$155	0.08%	156
2021 Q3	$228K	Buy	1,408 +130	+10%	+$21.9K	0.1%	153
2021 Q2	$209K	Sell	1,278 -95	-7%	-$14.6K	0.09%	155
2021 Q1	$207K	Hold	1,373	–	–	0.1%	144
2020 Q4	$208K	Buy	+1,373	New	+$196K	0.1%	144

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Cornell Pochily Investment Advisors's IBB Position: Q2 2026 in Review

Cornell Pochily Investment Advisors opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,140 shares worth $217K. The stake represents 0.06% of the portfolio and ranks #186 among its holdings. This is a return to the name: Cornell Pochily Investment Advisors previously reported a position in IBB as recently as Q4 2021.

Cornell Pochily Investment Advisors first reported a position in IBB in Q4 2020 and has held it in 6 quarters since. The position peaked at $228K in Q3 2021. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Cornell Pochily Investment Advisors held 1,140 shares of iShares Biotechnology ETF worth $217K as of Q2 2026.
iShares Biotechnology ETF was a new Cornell Pochily Investment Advisors position in Q2 2026.
iShares Biotechnology ETF made up 0.06% of Cornell Pochily Investment Advisors's portfolio in Q2 2026, its #186 holding.
Cornell Pochily Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 6 quarters since.
Cornell Pochily Investment Advisors's iShares Biotechnology ETF position peaked at $228K in Q3 2021.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cornell Pochily Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.